Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Leadership

Photo: Henry Rolka, MS, MHA

 

Henry Rolka, MS, MHA

Acting Director

Acting Assocate Director for Science

Division of Epidemiology, Analysis and Library Services

Center for Surveillance, Epidemiology, and Laboratory Services

Office of Public Health Scientific Services

Henry Rolka has worked for CDC since 1992 and is currently Senior Science Advisor and acting ADS in the Division of Epidemiology, Analysis, and Library Services (DEALS). His projects include leading an agency-wide working group to coordinate CMS data use activities at CDC and serving as liaison to the Statistical Advisory Group. He has previously served as Associate Director for Information Exchange in CDC’s Office of Critical Information Integration and Exchange, Senior Advisor to the National Center for Public Health Informatics, Branch Chief for the Statistical Analysis Branch of the National Immunization Program, one of the original members of the CDC Surveillance Systems Integration Project as well as a statistical consultant for the Epidemic Intelligence Service Officer’s Program. He was instrumental in the early implementation of the BioSense Program, served as CDC representative to the Defense Advanced Research Project Agency’s BioAlirt Program as well as the design review for the Department of Homeland Security’s National Biosurveillance Integration System and was the Chair of CDC’s Statistical Advisory Group from 2008-2010.

Henry completed a Master’s degree in Statistics at Kansas State University where his research included the application of non-linear models and the use of simulation techniques to evaluate them for dose-response applications. He also has a graduate degree in Health Services Administration as well as a clinical background as a Registered Nurse and in Human Intelligence in the US Army. His history with surveillance and countermeasure administration dates back to the 1970s when he managed a project to evaluate the use of a new vaccine in an endemic population in rural Africa.

Top